Quanta Pharma Halotestin 10mg x 30 tablets

£42.00

Description
Reviews (0)

Quanta Pharma Halotestin 10mg x 30 Tablets

Quanta Pharma Halotestin 10mg x 30 tablets provides a specialized anabolic-androgenic compound designed for advanced research into extreme strength augmentation and aggressive behavioral modulation. Containing fluoxymesterone, a potent 17-alpha-alkylated derivative of testosterone, this product serves as a critical tool for studying rapid anabolic responses and androgenic receptor binding affinity. Unlike milder compounds, fluoxymesterone exhibits a high ratio of androgenic to anabolic activity, making it unique for specific physiological investigations. Each bottle contains 30 tablets of 10mg, offering a controlled supply for short-duration, high-intensity study protocols. Quanta Pharma ensures strict adherence to purity standards, guaranteeing that researchers receive a chemically stable and accurately dosed substance for reliable data acquisition in animal and in vitro models.

Key Features

Extreme Potency: Fluoxymesterone is one of the most potent oral anabolic-androgenic steroids available for research
High Androgenic Rating: Ideal for studying strong androgenic receptor interactions and downstream effects
Rapid Action: Compound exhibits fast onset of physiological changes in observed subjects
Precision Dosing: 10mg tablets allow for accurate titration in sensitive research models
Limited Supply Pack: 30-tablet configuration suits short-cycle research protocols requiring strict control
Verified Purity: Manufactured with ≥99.8% chemical purity, verified by third-party HPLC testing
Stable Formulation: 17-alpha-alkylated structure ensures oral viability and metabolic resistance

Mechanism of Action

Fluoxymesterone functions by binding with high affinity to androgen receptors (AR) throughout the body, particularly in skeletal muscle and nervous system tissue. This binding triggers rapid upregulation of protein synthesis and nitrogen retention, though its primary research value lies in its profound impact on neuromuscular efficiency and aggression pathways. The compound does not aromatize into estrogen, eliminating estrogenic side effects such as water retention or gynecomastia in study subjects. Instead, it exerts strong androgenic effects that influence behavior, red blood cell production, and glycogenolysis. The 17-alpha-alkylation prevents first-pass metabolism in the liver, ensuring high bioavailability, though this also increases hepatotoxic potential in long-term exposure models.

Research Benefits

Maximum Strength Output: Significantly increases neuromuscular aggression and force production capabilities
Rapid Aggression Induction: Useful for studying behavioral changes linked to high androgen exposure
Red Blood Cell Stimulation: Enhances erythropoiesis, improving oxygen-carrying capacity in blood
Zero Estrogenic Activity: Provides a pure androgenic model without estrogen-related confounding variables
Glycogenolysis Promotion: Increases breakdown of glycogen to glucose, affecting energy metabolism studies
Muscle Hardening: Promotes dense tissue appearance without water retention in animal models

When to Use

This compound is designated for research requiring rapid, extreme androgenic stimulation. Utilize Quanta Pharma Halotestin when investigating the limits of strength enhancement and aggression in behavioral studies. Suitable for short-term protocols examining neuromuscular junction efficiency. Ideal for models studying the effects of non-aromatizing steroids on hematocrit levels. Appropriate for comparative analysis against other high-potency androgens. Not suitable for long-term bulking or mass-gain studies due to toxicity profiles.

Dosage Guidelines for Research

Standard Research Dosage: 10-40mg per day, strictly divided into multiple doses to manage blood concentration peaks
Cycle Duration: Limited to 2-4 weeks maximum due to high hepatotoxicity risks in animal subjects
Administration: Oral ingestion only; do not crush or alter tablet integrity before administration
Monitoring: Mandatory daily observation for liver distress, aggression levels, and hematocrit changes
Discontinuation: Immediate cessation required upon signs of severe toxicity or adverse behavioral changes
Post-Study: Implement recovery protocols for liver function monitoring post-exposure

Product Specifications

Compound: Fluoxymesterone (Halotestin)
Manufacturer: Quanta Pharma
Strength: 10mg per tablet
Quantity: 30 tablets per bottle
Chemical Class: 17-alpha-alkylated anabolic-androgenic steroid
Purity: ≥99.8% (HPC certified)
Form: Oral tablet
Storage: Store below 25°C in a dry, dark environment
Shelf Life: 3 years from manufacture date
Usage: Laboratory research and animal studies only

Conclusion

Quanta Pharma Halotestin 10mg x 30 tablets stands as a specialized and potent tool designed exclusively for high-intensity research applications where extreme androgenic effects are required. Its unique profile makes it indispensable for studies focusing on rapid strength augmentation, neuromuscular aggression, and hematological responses without the confounding variables of estrogenic activity. Researchers must approach this compound with a clear understanding of its high potency and associated toxicity risks, strictly adhering to short-duration protocols and rigorous monitoring standards. By providing a chemically pure and accurately dosed formulation, Quanta Pharma enables precise investigation into the upper limits of androgenic receptor modulation. This product is not intended for general wellness or long-term use but serves as a critical asset for specific, controlled scientific inquiries into the profound effects of powerful anabolic-androgenic substances.